Flow cytometry is a laser- or pressure-based biotechnology
technique that is used to analyze characteristics such as cell size, cell
count, and marker expression on cell surfaces or inside cells. Flow cytometry
allows simultaneous multiparametric analysis of the physical and chemical
characteristics of up to thousands of particles per second. Flow cytometry
enables researchers to dissect single-cell heterogeneity, measure protein
levels and activities inside single cells, and characterize rare populations of
cells. It serves applications in areas such as immunology, cancer research,
hematology, and stem cell research. The growing requirement for analytical
techniques that enable detection and analysis at single-cell resolution is one
of the major factors fueling the demand for flow cytometers globally.
Additionally, the increasing prevalence of cancer and rising research
activities in the areas of drug discovery and stem cell therapy are also
boosting the adoption of flow cytometry.
The global Flow Cytometry Market is estimated to be valued
at US$ 245.0 Mn in 2024 and is
expected to exhibit a CAGR of 14.%
over the forecast period 2024 to 2030.
Key Takeaways
Key players operating in the Flow Cytometry are Google Inc., Apple Inc., Rethink
Robotics, BAE Systems, Narrative Science Inc., Creative Virtual Ltd., Microsoft
Corporation, Digital Reasoning Systems, Inc., and IBM Corporation.
Key opportunities in the
Flow
Cytometry Market Trends include growing research on cancer
immunotherapy and stem cells. Flow cytometry plays a crucial role in cancer
immunotherapy by analyzing phenotypic and functional characteristics of immune
cells, monitoring vaccination responses and tracking engraftment of donor
immune cells post-transplant. Research on stem cell therapy is also driving
opportunities for flow cytometry due to its ability to characterize and isolate
stem cells through analysis of cell surface markers.
North America accounts for the largest share in the global flow cytometry
market owing to the high adoption of novel technologies for research and
clinical applications. However, Asia Pacific region is anticipated to witness
highest growth over the forecast period due to increasing government support
for life sciences research, large patient pools and rising awareness about
clinical applications of flow cytometry. Key players operating in the Asia
Pacific region are focusing on expansion of their production and distribution
networks to leverage growth opportunities in the emerging economies.
Market Drivers
Increasing incidence and prevalence of chronic diseases such as cancer is
Flow
Cytometry Market Size and trends. Flow cytometry facilitates early
detection of cancer through identification of biomarkers and also plays a vital
role in monitoring disease progression and treatment response.
Market Restrains
High cost of flow cytometry instruments and lack of skilled professionals are
some of the key factors inhibiting the widespread adoption of flow cytometry
globally. Flow cytometers equipped with advanced features require substantial
capital investments, restricting their adoption in resource limited settings.
Lack of trained technical staff further challenges the optimal utilization of
these sophisticated analysis platforms.
Segment
Analysis
The global flow cytometry market is dominated by clinical application segment.
Flow cytometry finds wide application in disease diagnosis thus clinical
segment accounts for over 60% market share. Within clinical application,
immunology dominates as flow cytometry helps observe immune cells and
abnormalities. Flow cytometry helps diagnose HIV, leukemia and other blood
cancers at early stages which drives immunology sub segment growth. Research
application segment is fastest growing segment and expected to witness CAGR of
16% during forecast period. Increasing collaborations between pharma companies
and research institutes to develop novel therapies will support research
segment growth in coming years.
Global Analysis
North America holds leading share of over 35% in global flow cytometry market
owing to developed healthcare infrastructure and increasing R&D investments
in pharma and biotech industry. Presence of leading flow cytometry companies
and availability of reimbursement policies drives the market in the region.
Asia Pacific is fastest growing region and expected to witness CAGR of 17%
during forecast period. Improving healthcare facilities, rising medical tourism
and increasing cancer incidence in countries like China and India supports
regional market growth. Lack of skilled professionals and high flow cytometry
equipment cost restricts the market growth in underdeveloped regions. Rise in
immunotherapy and stem cell research activities will create growth
opportunities for market players globally in coming years.
Get More
Insights on- Flow
Cytometry Market
Comments
Post a Comment